MTPConnect Opens New Funding Round for Medtech Innovators in Heart Disease and Diabetes
We opened a new funding opportunity providing up to $1 million through our new TTRA initiative to help eligible Australian start-ups and SMEs develop innovative devices for cardiovascular disease and diabetes (type 1 and type 2). Applications close 30 March 2026. Check out the information session webinar for further details.
WAGES New Commercialisation Grant Development Workshop
EOIs will be opening soon for the Commercialisation Grant Development Workshop to be held on 22 April 2026 at Curtin University. Designed to help WA innovators and start-ups turn their great ideas into funded ventures. Check out the WAGES website and sign up to the mailing list for updates and follow on new LinkedIn page.
WA Grant Excellence Service Calls for Expert Peer Reviewers
MTPConnect, in partnership with Synergy Health Solutions, is inviting Expressions of Interest from experienced researchers to join our WA Grant Excellence Service (WAGES) as an expert reviewer. Help to grow WA’s health and medical innovation sector. EOIs open now
More Action Needed on Superbugs
Coinciding with the AMR 2026 Summit in Sydney, AAMRNet’s call for the Australian Government to support a subscription fund to help Australians access new antimicrobials and to incentivise their development, was covered in a story in The Sydney Morning Herald, and on national radio. AAMRNet’s co-chair, MTPConnect’s Andrew Bowskill took part in the Summit, facilitating a panel of AMR global experts including Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance and connecting with key national and international stakeholders from industry, research, clinicians, patients and government.
MTPConnect and Wholesale Investor’s Life Sciences Investor Day Hits the Mark
We wrapped up our inaugural Life Sciences Investor Day at Emergence 2026 in partnership with Wholesale Investor – showcasing 30+ life science companies to investors. Great to be able to bring investors and founders together in this forum in Sydney and make some connections to look at the next high-growth opportunities shaping global healthcare and help bring new Australian medical products to the world! Check out the on-demand video to see the presentations and pitches.
New Year, New Season of the MTPConnect Podcast!
We kicked off season 8 of the podcast i by catching up again with US FDA Expert and lawyer, Jeff Gibbs about navigating regulatory pathways in the US for medical devices. Find out Jeff’s top tips and advice on the medical device review process including pre-submissions and how best to engage with the agency.
TTRA Delegation Hits San Diego To Make Connections for Diabetes and Cardiovascular Innovations
MTPConnect was in San Diego hosting a delegation of innovative Australian biotech companies supported through our inaugural Targeted Translation Research Accelerator initiative – Inosi Therapeutics, Endo Axiom, Lorikeet Therapeutics and Nanomedx. The group took in an ecosystem tour to key US life sciences companies before heading to the ‘Biocom Global Partnering & Investor Conference to attend keynote sessions, schedule partnering meetings, make presentations and gather connections!
TTRA Drugs and Devices Cohort Come Together for Commercialisation Intensive
Twelve breakthrough companies came together as part of MTPConnect’s Targeted Translation Research Accelerator (TTRA) Drugs & Devices cohort for two days in Sydney, a valuable opportunity to share insights, challenges, and lessons on the realities of translation and commercialisation.
Watch Innovation to Impact Stories from MTPConnect Programs
Take a look at our new video featuring some of the remarkable Australian companies and organisations developing innovative products and solutions for better health – backed by our highly sought after commercialisation support programs like Targeted Translation and Research Accelerator (TTRA) and the Clinical Translation Commercialisation Medtech program (CTCM).